
Clinical research firm Profil Institute has appointed former Amylin chief executive Dan Bradbury to its Board of directors. “Dan Bradbury …

The BioIndustry Association (BIA) has said that the UK is clearly the must-go-to location for regenerative medicine research and development. …

Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …

Bristol-Myers Squibb has filed its investigational hepatitis C treatment – the first oral regime without interferon or ribavirin – with …

Astellas has hired Jeffrey Winton from Eli Lilly to be its senior vice president and chief communications officer.Winton who will …

GlaxoSmithKline is unlikely to face a company-wide charge for corruption following investigations by authorities in China according to reports. The …


On Tuesday 1 October, three years after it was passed, the Patient Protection and Affordable Care Act came into force …

Ariad Pharmaceuticals has been forced by the FDA to suspend sales of its blood cancer drug Iclusig given the high …

AstraZeneca’s third quarter revenues and profits fell below analysts’ expectations yesterday, but mitigated the news with the appointment of a …

AstraZeneca has confirmed that Marc Dunoyer has been appointed chief financial officer and will join the company’s Board as an …
Publicis Groupe has announced that its digital health agency Heartbeat Ideas has joined Saatchi & Saatchi Health in the US. …